5VOM
Benzopiperazine BET bromodomain inhibitor in complex with BD1 of Brd4
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
Synchrotron site | Australian Synchrotron |
Beamline | MX2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2012-07-04 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.9537 |
Spacegroup name | P 1 |
Unit cell lengths | 30.210, 39.385, 55.506 |
Unit cell angles | 95.05, 104.14, 91.58 |
Refinement procedure
Resolution | 39.180 - 1.670 |
R-factor | 0.17726 |
Rwork | 0.175 |
R-free | 0.21777 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.010 |
RMSD bond angle | 1.469 |
Data reduction software | XDS |
Data scaling software | XDS |
Phasing software | PHASER |
Refinement software | REFMAC (5.7.0029) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 39.180 | 1.770 |
High resolution limit [Å] | 1.660 | 1.660 |
Rmerge | 0.089 | 0.382 |
Number of reflections | 27843 | |
<I/σ(I)> | 13.6 | |
Completeness [%] | 96.1 | 90.7 |
Redundancy | 4.2 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 6.8 | 291 | 30% PEG 4000, 0.1 M MES pH 6.8 |